TIDMITX

RNS Number : 9160Q

Itaconix PLC

24 June 2020

THIS ANNOUNCEMENT, AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, THE REPUBLIC OF IRELAND, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. PLEASE SEE THE IMPORTANT NOTICES AT THE END OF THIS ANNOUNCEMENT AND AT THE START OF THE APPENDIX.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN ORCHID PLC OR ANY OTHER ENTITY IN ANY JURISDICTION. NEITHER THIS ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION, SHALL FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION WITH ANY INVESTMENT DECISION IN RESPECT OF ITACONIX PLC.

Itaconix plc

("Itaconix" or the "Company")

Close of Accelerated Bookbuild

The Company is pleased to announce that further to the announcement made yesterday on 23 June 2020 at 5.31 p.m., the Bookbuild has been successful, was oversubscribed and has now closed. Participants in the Placing will be contacted by N+1 Singer and Allenby Capital later today to confirm their allocations. A further announcement will be made in due course confirming details of the Fundraise . The Company reserves the right to increase the overall size of the Fundraise.

Admission of the First Placing Shares and the Second Placing Shares is conditional, inter alia, upon the Placing Agreement not having been terminated and becoming unconditional in respect of those shares. Admission of the Second Placing Shares is also conditional on the passing of the resolutions by Shareholders at the General Meeting.

Save as otherwise defined, capitalised terms used in this announcement have the meanings given to them in the announcement released by the Company at 5.31pm on 23 June 2020.

Ends

For further information please contact:

 
 
 Itaconix Plc                                 +44 (0) 1244 283 500 
 John Shaw, Chief Executive Officer 
 Laura Denner, Chief Financial Officer and 
  Company Secretary 
 www.itaconix.com 
 
 N+1 Singer (Nominated Adviser and Joint 
  Broker)                                     +44 (0) 207 496 3000 
 Peter Steel / James Moat 
  Tom Salvesen 
 
 Allenby Capital Limited (Joint Broker)       +44 (0) 203 328 5656 
 Amrit Nahal (Broking) 
  Nick Athanas / Liz Kirchner (Corporate 
  Finance) 
 

About Orchid

Orchid plc (LSE: ITX) is a leading innovator in bio-based functional ingredients for improving the safety and performance of homecare, personal care, and industrial products. Its proprietary polymer technology generates a growing range of new ingredients with unique functionality that meet consumer demands for value and sustainability.

www.orchid.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCKKQBNABKKDAB

(END) Dow Jones Newswires

June 24, 2020 02:55 ET (06:55 GMT)

Grafico Azioni Itaconix (LSE:ITX)
Storico
Da Dic 2020 a Gen 2021 Clicca qui per i Grafici di Itaconix
Grafico Azioni Itaconix (LSE:ITX)
Storico
Da Gen 2020 a Gen 2021 Clicca qui per i Grafici di Itaconix